Depression Clinical Trials in Florida

66 recruiting studies across 4 cities

Browse by City

Miami

All Trials in Florida

Phase

Trial	Phase	Sponsor	Dist.
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment	N/A	Mayo Clinic	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients	Phase 2	Mayo Clinic	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
Potential Benefits of Parent Child Interaction Therapy (PCIT)	—	University of Florida	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	<1 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients	Phase 2	Hospital Italiano de Buenos Aires	<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	Phase 2	Tonix Pharmaceuticals, Inc.	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	<1 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	<1 mi
The Lake Nona Life Project	—	University of Central Florida	<1 mi
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics	N/A	AdventHealth	<1 mi
Adapting Single Sessions Interventions for Type 1 Diabetes	N/A	Nemours Children's Health System	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Cocooned Moms Study	N/A	InovCares Connected Comprehensive Healthcare Corporation	<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	Phase 4	Neurocrine Biosciences	<1 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	<1 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Lay-Delivered Behavioral Activation in Senior Centers	N/A	University of Washington	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics	N/A	University of South Florida	<1 mi
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study	—	Duke University	<1 mi
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV	N/A	University of Miami	<1 mi
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV	N/A	Florida International University	<1 mi
Neural and Psychiatric Consequences of Cannabis Use in Adolescents	N/A	University of Miami	<1 mi
Mental Health in Primary Care	N/A	University of Miami	<1 mi
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)	N/A	Florida International University	<1 mi
Implementing Depression and Adherence Treatment	N/A	University of Miami	<1 mi
ENA-001 for Opioid Induced Respiratory Depression	Phase 1	Enalare Therapeutics Inc.	<1 mi
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms	—	Qbtech AB	<1 mi
Families With Pride ("Familias Con Orgullo").	N/A	University of Miami	6 mi
Geolocation Positional System (GPS) Experience	N/A	University of Miami	6 mi
Unified Protocol: Community Connections	N/A	University of Miami	6 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	6 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	10 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	11 mi
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women	N/A	BTL Industries Ltd.	13 mi
The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program	N/A	Nova Southeastern University	25 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	26 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.